Image may be NSFW.
Clik here to view.
Clik here to view.
NeoStem completing enrollment in heart trial
NeoStem (NASDAQ:NBS) is on track to complete enrollment later this year in a Phase 2 clinical trial of a bone marrow-derived cell therapy to treat patients for acute myocardial infarction, with a data...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Dipexium advancing EU approval strategy for Locilex
With its Phase 3 program underway in the U.S., Dipexium (NASDAQ:DPRX) has begun the regulatory process with the European Medicines Agency (EMA) for its Locilex topical treatment for diabetic foot...
View Article
More Pages to Explore .....
